NCT03561675View on ClinicalTrials.gov

Effect of Acetazolamide on Acute Mountain Sickness in Lowlanders Older Than 40 Years

PHASE4CompletedINTERVENTIONAL
Enrollment

349

Participants

Timeline

Start Date

May 15, 2018

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions
Acute Mountain Sickness
Interventions
DRUG

ACETAZOLAMIDE oral capsule

Administration of 1x125mg acetazolamide in the morning, 2x125mg in the evening, starting 24 hours before departure to 3'100m

DRUG

Placebo oral capsule

Administration of equally looking placebo capsules in the morning and evening, starting 24 hours before departure to 3'100m

Trial Locations (1)

720040

National Center of Cardiology and Internal Medicine, Bishkek

All Listed Sponsors
collaborator

National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov

OTHER_GOV

lead

University of Zurich

OTHER

NCT03561675 - Effect of Acetazolamide on Acute Mountain Sickness in Lowlanders Older Than 40 Years | Biotech Hunter | Biotech Hunter